Home › Occupations › Biochemists and Biophysicists › Palo Alto, CA
Biochemists and Biophysicists in Palo Alto, CA: H-1B salaries
50 labor condition applications for this occupation with a work site in Palo Alto, CA. Median offered base salary $82,000; middle half $75,000–$103,000.
By wage level
| Wage level | Median salary |
|---|---|
| Level I (entry) | $80,000 |
| Level II (qualified) | $90,290 |
| Level III (experienced) | $130,000 |
| Level IV (fully competent) | $140,000 |
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Employers
| Employer | LCAs | Median salary |
|---|---|---|
| The Leland Stanford, Jr University | 28 | $80,250 |
| Palo Alto Veterans Institute for Research | 6 | $72,509 |
| Pumpkinseed Technologies, Inc | 3 | $139,200 |
| Kodiak Sciences Inc. | 2 | $144,850 |
| NextVivo, Inc. | 2 | $140,000 |
| Arc Research Institute | 2 | $101,000 |
| Baylink Biosciences Inc. | 2 | $82,000 |
| Sastra Cell Therapy | 1 | $140,000 |
| Interface Biosciences, Inc | 1 | $90,000 |
| BioMap Inc. | 1 | $83,200 |
| Centrillion Technologies, Inc. | 1 | $85,000 |
| Schrodinger, Inc. | 1 | $175,000 |
Job titles
- Postdoctoral Research Affiliate9
- Basic Life Research Scientist5
- Scientist4
- Physical Science Research Scientist4
- Life Sciences Research Associate I4
- Life Science Research Professional 13
- Senior Research Scientist3
- Life Science Research Professional 22
- Research Scientist2
- Clinical Manufacturing Quality Control Analyst 31
- Sr Res Scientist - Basic Life1
- Senior Quality Specialist1
- Instructor1
- LC-MS Scientist1
- Scientist II1
H-1B sponsors in Palo Alto, CA →
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).